I 2004 udkom to publikationer, der beskrev en på forhånd planlagt reanalyse af det kliniske udviklingsprogram for prostatacancer i tidligt stadium (Early Prostate Cancer (EPC)) for Casodex (bicalutamid).
In 2004, 2 publications were published detailing a pre-planned 2nd analysis of the Casodex (bicalutamide) Early Prostate Cancer (EPC) study programme.